.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Evaluating Therapeutic Options in Chronic Lymphocytic Leukemia

EP. 1: What Testing is Done Alongside a Diagnosis of CLL?

December 27th 2018

EP. 2: Chronic Lymphocytic Leukemia: Selecting Initial Therapy

December 27th 2018

EP. 3: Understanding the Timing of Therapy in CLL

December 27th 2018

EP. 4: Relapsed CLL: Factors in Choosing Therapy

December 27th 2018

EP. 5: Impacting CLL Management With Lifestyle Modification

December 27th 2018

EP. 6: Moving the Paradigm of CLL Management Forward

December 27th 2018

EP. 7: Confirming a Diagnosis of CLL

December 27th 2018

EP. 8: Role of Watchful Waiting in CLL

December 27th 2018

EP. 9: Indications for Initiating Therapy in CLL

December 27th 2018

EP. 10: Tests Used to Inform Treatment Decisions in CLL

December 27th 2018

EP. 11: Chemoimmunotherapy in CLL

December 27th 2018

EP. 12: Clinical Trial Participation in CLL

December 27th 2018

EP. 13: Considering a Clinical Trial for CLL Treatment

December 27th 2018

EP. 14: Danise: Experience With Venetoclax Targeted Therapy

December 27th 2018

EP. 15: Managing Side Events From Targeted Therapy for CLL

December 27th 2018

EP. 16: CLL Management: Establishing a Network of Support

December 27th 2018

EP. 17: Navigating Through CLL Treatment

December 27th 2018

Latest News

Medicaid Expansion Associated With Improved Breast Cancer Outcomes

Despite Rapid Increase in Immunotherapy Use for Lung Cancer, Survival Benefit for Older Patients Is Modest

I’m No Longer Stubborn When It Comes to Cancer Screenings

Teaching Children — and the World — to Use Breathing Techniques for Cancer-Related Pain

View More Latest News